They must be backed up at FDA for obtaining review of resubmission of 510k. Two months have gone bye on the fast tract. I think since they reviewed it before, the new data showing benefit without any negative reactions would be an easy approval. Any day now we shall hear hopefully the news we been anxious for. I am surprised that pps since Jan 8th has been between .0007-.0009 even with several billions shares trading hands.